Additional, specialized radiation not necessary for some women after mastectomy
After mastectomy, breast cancer patients who receive radiation treatment to the lymph nodes located behind the breast bone do not live longer than those who do not receive radiation to this hard-to-treat area, according to a randomized 10-year study presented at the plenary session, November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO). Breast cancer that is located in an internal, central location in the breast area, and larger tumors that have spread to the lymph nodes located under the arm (axillary) and just above the collar bone (supraclavicular), are more likely to spread to the internal mammary lymph nodes that are located behind the breast bone.
The type of external beam radiation treament used to treat these patients is called internal mammary chain radiation treatment, or IMC-RT. It is challenging to deliver the proper dose of radiation to the internal mammary chain because it is hard to define its exact location and to protect critical organs, such as the heart and lung.
"This is the first study that answers the important question of whether radiation to the internal mammary chain lymph nodes benefit these patients after 10 years of follow-up," Pascale Romestaing, M.D., lead author of the study and a radiation oncologist at Centre de Radiothérapie Mermoz in Lyon, France said. "Our findings clearly show that it does not affect overall survival. These women still need radiation treatments – just not additional radiation to these specialized cells."
During external beam radiation therapy, a beam (or multiple beams) of radiation is directed through the skin to the cancer and the immediate surrounding area in order to destroy the main tumor and any nearby cancer cells. The treatments are outpatient and generally painless, much like receiving an X-ray.
The multicenter randomized trial involved 1,334 women newly-diagnosed with stage 1 or 2 breast cancer who had undergone a mastectomy, or surgery to remove a breast. Patients had either cancer that had spread to the axillary lymph nodes or their original tumor was in an internal, central location in the breast area. While all patients received radiation to the chest wall and supraclavicular lymph nodes, one-half of the patients were randomized to also receive the specialized IMC radiation treatment.
After 10 years, researchers found no significant differences in survival rates between the group who received IMC radiation treatment (63 percent) and those who did not (60 percent). The study also found no differences in survival for patients in the study who were analyzed in subgroups. These groups included whether or not their cancer had spread to their lymph nodes, where their original tumor was located, and whether they also underwent chemotherapy or hormone therapy at the same time they had radiation treatment.
Source: American Society for Radiation Oncology
Articles on the same topic
- Radiation therapy after lumpectomy for breast cancer can be safely reduced to 4 weeks15 years ago
- 3-week course of breast radiation may be as effective as conventional 5- to 7-week course for early breast cancers15 years ago
- Does race, income predict prostate cancer outcome?15 years ago
- Cancer patients want honesty, compassion from their oncologist15 years ago
- Shorter radiation course stops cancer growth in high-risk prostate cancer patients15 years ago
- Shorter radiation course as effective as standard therapy for prostate cancer recurrence15 years ago
- Radiation therapy technique successfully treats pain in patients with advanced cancer15 years ago
- PET imaging before radiation not ideal for determining boost radiation doses15 years ago
- Obesity significantly increases side effects of stereotactic body radiation therapy in lung cancer patients15 years ago
- Proton therapy is well-tolerated in prostate cancer patients15 years ago
- Stereotactic radiotherapy stops lung cancer from growing in frail patients15 years ago
- Stereotactic radiotherapy stops lung cancer from growing in frail patients15 years ago
- Stereotactic radiotherapy offers noninvasive, effective treatment for lung cancer patients15 years ago
- Adding proton therapy 'boost' to X-ray radiation therapy reduces prostate cancer recurrences15 years ago
- Short-term hormone therapy and intermediate dose radiation increases survivial for early stage prostate cancer15 years ago
- Preventative brain radiation for lung cancer patients: Benefits and risks15 years ago
- Undetectable PSA after radiation is possible and predicts good patient outcomes15 years ago
- Real benefits vs. risks of preventative brain radiation for nonsmall cell lung cancer patients15 years ago
- Radiation after surgery reduces chance of melanoma returning15 years ago
- Short-term hormone therapy added to radiation increases survival for medium-risk, but not low-risk, prostate cancer patients15 years ago
Other sources
- Irradiated cancers stay downfrom Science Alert15 years ago
- Radiation therapy after lumpectomy for breast cancer can be safely reduced to 4 weeksfrom Physorg15 years ago
- Cancer patients want honesty, compassion from their oncologistfrom Physorg15 years ago
- Radiation therapy technique successfully treats pain in patients with advanced cancerfrom Science Blog15 years ago
- PET imaging before radiation not ideal for determining boost radiation dosesfrom Physorg15 years ago
- Radiation Therapy Technique Successfully Treats Pain In Patients With Advanced Cancerfrom Science Daily15 years ago
- Radiation therapy technique successfully treats pain in patients with advanced cancerfrom Physorg15 years ago
- Additional, specialized radiation not necessary for some women after mastectomyfrom Physorg15 years ago
- Adding proton therapy 'boost' to X-ray radiation therapy reduces prostate cancer recurrencesfrom Physorg15 years ago
- Proton Therapy Is Well-tolerated In Prostate Cancer Patientsfrom Science Daily15 years ago
- Stereotactic radiotherapy stops lung cancer from growing in frail patientsfrom Physorg15 years ago
- Preventative brain radiation for lung cancer patients: Benefits and risksfrom Physorg15 years ago
- Proton therapy is well-tolerated in prostate cancer patientsfrom Physorg15 years ago
- Undetectable PSA after radiation is possible and predicts good patient outcomesfrom Physorg15 years ago
- Radiation after surgery reduces chance of melanoma returningfrom Physorg15 years ago
- Obesity significantly increases side effects of stereotactic body radiation therapy in lung cancer patientsfrom Physorg15 years ago
- Preventative brain radiation for lung cancer patients: Benefits and risksfrom Science Blog15 years ago
- Short-term hormone therapy and intermediate dose radiation increases survivial for early stage prostate cancerfrom Physorg15 years ago
- Stereotactic Radiotherapy Offers Noninvasive, Effective Treatment for Frail Patients with Early-stage Lung Cancerfrom Newswise - Scinews15 years ago
- Undetectable PSA After Radiation Is Possible And Predicts Good Patient Outcomesfrom Science Daily15 years ago
- Radiation After Surgery Reduces Chance Of Melanoma Returningfrom Science Daily15 years ago